Menu
Search
- News
- Economy
- Central Banks
- Investing
- Research
- Roundups
- Digital Currency
- Insights
- Technical Analysis
- Technology
- Business
- Law
- Health
- Nature
- Fintech
- Science
- Topic
- Opinions
- ©Econometrics LLC . All Rights Reserved.
Barbara Jacquelyn Sahakian
Professor of Clinical Neuropsychology, University of Cambridge
Professor Barbara J Sahakian DSc FBA FMedSci
Professor Barbara J Sahakian is based at the University of Cambridge Department of Psychiatry and Behavioural and Clinical Neuroscience Institute. Sahakian is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital and a Fellow of Clare Hall, Cambridge. She is a Fellow of the British Academy and the Academy of Medical Sciences. She was a Member of the International Expert Jury for the 2017 Else Kröner-Fresenius-Stiftung Prize. She is a Past President of the British Association for Psychopharmacology and of the International Neuroethics Society. Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. She is best known for her work on problems of cognition and motivation in brain injury, ‘hot’ and ‘cold’ cognitive deficits in depression and early detection and early treatment with cholinesterase inhibitors in Alzheimer’s disease. She has over 475 publications in high impact scientific journals. The ISI Web of Science database credits her with a Hirsch (h) index of 130 and Google Scholar h-index of 143. Sahakian co-invented the neuropsychological CANTAB and EMOTICOM tests (www.cambridgecognition.com) and the University of Cambridge/PEAK Advanced Training Programme and the Wizard Apprentice Memory Game (www.peak.net) . Sahakian has contributed to Neuroscience and Mental Health Policy, including the UK Government Foresight Project on Mental Capital and Wellbeing (Beddington et al., 2008, Nature), the Strategy for Mental Health for the Medical Research Council (Sahakian et al., 2010, The Lancet) and the Grand Challenges in Global Mental Health (Collins et al., 2011, Nature). She was a member of the Institute of Medicine Planning Committee (USA) on Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression. She is on the Committee for the Strategy for Neuroscience and Mental Health for the Department of Health. In March 2017, she participated in the Global Council on Brain Health meeting in Washington, DC. She has spoken at the World Economic Forum, Davos, 2014 and is a member of the WEF on the Future of Neurotechnologies and Brain Science. She is also on the Clinical Advisory Board of the Human Brain Project. She is a member of the Wellcome Trust Science Innovation Translation Programme Advisory Group and the Wellcome’s Innovator Awards Advisory Group. She is a member of the Irish Research Council Laureate Awards Committee.
How antidepressants, ketamine and psychedelic drugs may make brains more flexible – new research
Oct 24, 2023 09:31 am UTC| Health
The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people dont respond to these...
Cognitive flexibility: the science of how to be successful in business and at work
Apr 14, 2023 14:12 pm UTC| Health
The word permacrisis was selected as the word of the year for 2022, referring to a feeling of being permanently in crisis. The business world has certainly faced continuous and increasingly frequent disruptions over the...
Emotional 'blunting' and antidepressants – new research suggests why this is happening
Jan 26, 2023 11:58 am UTC| Health
Reinforcement sensitivity is an important behavioural process that allows us to learn from our environment through either positive/rewarding or negative feedback. When we get together with friends or go for a run,...
Vaccine passports: why they are good for society
May 16, 2021 12:24 pm UTC| Technology
As more and more people get vaccinated, some governments are relying on vaccine passports as a way of reopening society. These passports are essentially certificates that show the holder has been immunised against...
How chronic stress changes the brain – and what you can do to reverse the damage
Mar 12, 2020 17:31 pm UTC| Health
A bit of stress is a normal part of our daily lives, which can even be good for us. Overcoming stressful events can make us more resilient. But when the stress is severe or chronic for example caused by the breakdown of a...
Cheap diuretic pill could help with autism symptoms
Jan 28, 2020 08:23 am UTC| Health
It is possible to improve symptoms in autistic children with a cheap generic drug, our latest study shows. The drug, bumetanide, is widely used to treat high blood pressure and swelling, and it costs no more than 10 for a...
The idea that US interest rates will stay higher for longer is probably wrong
Impact of Iran-Israel conflict on Stocks, Gold and Bitcoin
Japan Posts 7.7% Growth in Machinery Orders
Why Africa can be the beating heart of South Korea’s technology industry
How cuts to marginal income tax could boost the UK’s stagnant economic growth
US Commerce Secretary Asserts Huawei Chip Lag, Affirms Export Control Success
Putin’s Russia: first arrests under new anti-LGBT laws mark new era of repression
Nvidia RTX 4090D Embroiled in US-China Tech Rivalry; South Korea Navigates Chip Export Dilemma
Canada needs a national strategy for homeless refugee claimants
Who will Trump pick as his running mate?
Could a telescope ever see the beginning of time? An astronomer explains
If life exists on Jupiter’s moon Europa, scientists might soon be able to detect it
Amazon to Introduce Air Delivery Service in Arizona via Drone
Rivian's Earth Day Special: $5,000 Off for Trading Gas Cars for Electric
China's EV Price Battle Intensifies with Tesla's Strategic Cuts
Apple Buys French AI Firm to Boost Privacy-Focused On-Device Processing
Shytoshi Kusama Secures $12M for Shiba Inu's New Layer-3 Blockchain
- Market Data
